In suggesting that academe and industry need to work more closely together, Mark Samuels is revisiting one of the central aims of LINK – launched by the government in 1988 and running well into the 2000s (“‘Culture change’ or pharma coma”, News, 5 February). Several biotechnology programmes drew together the pharmaceutical and chemical industries with academic departments across the UK in a wide-ranging selection of projects often involving collaboration between many companies and several universities.
Although I agree with the thrust of Samuels’ thinking, I would suggest that he may have underestimated the amount of time and effort needed to make collaborative projects work, especially in leading-edge research areas. My experience in putting programmes and projects together is that risk of failure to launch, even at the last moment, coupled with the likelihood that much leading-edge research may go nowhere fast, may seriously inhibit those who might champion and participate in collaborative projects. I worked in a culture where attributing blame was not always a priority and where occasionally winging it was, if not openly encouraged, at least well tolerated: today’s climate seems to be rather different.
Register to continue
Get a month's unlimited access to THE content online. Just register and complete your career summary.
Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:
- Sign up for the editor's highlights
- Receive World University Rankings news first
- Get job alerts, shortlist jobs and save job searches
- Participate in reader discussions and post comments
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?Sign in now